Pyrazolo[1,5-a]pyrimidin-7(4H)-one, 5-methyl-2,3-diphenyl-6-(6-quinolinyl)- manufacturers
- AGI25696
-
- $2500.00
-
2026-04-21
- CAS:2201065-84-9
- Purity:
- Supply Ability: 10g
|
| | Pyrazolo[1,5-a]pyrimidin-7(4H)-one, 5-methyl-2,3-diphenyl-6-(6-quinolinyl)- Basic information |
| | Pyrazolo[1,5-a]pyrimidin-7(4H)-one, 5-methyl-2,3-diphenyl-6-(6-quinolinyl)- Chemical Properties |
| Boiling point | 641.7±65.0 °C(Predicted) | | density | 1.28±0.1 g/cm3(Predicted) | | pka | 4.46±0.10(Predicted) |
| | Pyrazolo[1,5-a]pyrimidin-7(4H)-one, 5-methyl-2,3-diphenyl-6-(6-quinolinyl)- Usage And Synthesis |
| Description | AGI-25696 is a MATA2 inhibitor that are useful as therapeutic agents for treating malignancies. AGI-25696 showed in vivo activity in MTAP null tumors. Note: The correct structure of AGI-25696 is CAS#2201065-84-9. Many vendors mistakenly listed CAS#2201066-35-3 as its AGI25696. J. Med. Chem. 2021, 64, 8, 4430–4449 published AGI25696 structure (it is CAS#2201065-84-9). |
| | Pyrazolo[1,5-a]pyrimidin-7(4H)-one, 5-methyl-2,3-diphenyl-6-(6-quinolinyl)- Preparation Products And Raw materials |
|